Crosstalk Between Adrenergic and Toll‐Like Receptors in Human Mesenchymal Stem Cells and Keratinocytes: A Recipe for Impaired Wound Healing
暂无分享,去创建一个
R. Isseroff | J. Nolta | M. Dasu | Benjamin R Lin | T. Peavy | F. Gorouhi | Thi Dinh La | C. Nguyen | Sandra Ramírez | Chelcy Mashburn | Heather Stewart | B. Lin
[1] Xueer Wang,et al. Activin B Promotes BMSC-Mediated Cutaneous Wound Healing by Regulating Cell Migration via the JNK-ERK Signaling Pathway. , 2014, Cell transplantation.
[2] Min Zhang,et al. Activin B promotes BMSC-mediated cutaneous wound healing by regulating cell migration via the JNK-ERK signaling pathway. , 2014, Cell transplantation.
[3] R. Isseroff,et al. Catecholamine stress alters neutrophil trafficking and impairs wound healing by β2 adrenergic receptor mediated upregulation of IL-6 , 2013, The Journal of investigative dermatology.
[4] R. Isseroff,et al. Successful treatment of a chronic venous leg ulcer using a topical beta-blocker. , 2013, Journal of the American Academy of Dermatology.
[5] P. Peplow,et al. A review of the influence of growth factors and cytokines in in vitro human keratinocyte migration. , 2013, Cytokine.
[6] Ç. Tükel,et al. Epithelial Cells Augment Barrier Function via Activation of the Toll-Like Receptor 2/Phosphatidylinositol 3-Kinase Pathway upon Recognition of Salmonella enterica Serovar Typhimurium Curli Fibrils in the Gut , 2012, Infection and Immunity.
[7] T. Kadowaki,et al. Adiponectin Regulates Cutaneous Wound Healing by Promoting Keratinocyte Proliferation and Migration via the ERK Signaling Pathway , 2012, The Journal of Immunology.
[8] L. Maeng,et al. Phorbol myristate acetate differentiates human adipose-derived mesenchymal stem cells into functional cardiogenic cells. , 2012, Biochemical and biophysical research communications.
[9] R. Isseroff,et al. Toll-like receptors in wound healing: location, accessibility, and timing. , 2012, The Journal of investigative dermatology.
[10] J. Carvalheira,et al. Topical Insulin Accelerates Wound Healing in Diabetes by Enhancing the AKT and ERK Pathways: A Double-Blind Placebo-Controlled Clinical Trial , 2012, PloS one.
[11] Su-Ji Min,et al. Major stress hormones suppress the response of macrophages through down-regulation of TLR2 and TLR4. , 2012, The Journal of surgical research.
[12] R. Isseroff,et al. Toll-like receptors and diabetes: a therapeutic perspective. , 2012, Clinical science.
[13] R. Kirsner,et al. Topical Timolol for a Refractory Wound , 2012, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[14] R. Tuan,et al. Concise Review: Clinical Translation of Wound Healing Therapies Based on Mesenchymal Stem Cells , 2012, Stem cells translational medicine.
[15] V. Wheelock,et al. Genetically Engineered Mesenchymal Stem Cells as a Proposed Therapeutic for Huntington’s Disease , 2011, Molecular Neurobiology.
[16] M. J. Chalmers,et al. Ligand-dependent perturbation of the conformational ensemble for the GPCR β2 adrenergic receptor revealed by HDX. , 2011, Structure.
[17] E. Badiavas,et al. Potential benefits of allogeneic bone marrow mesenchymal stem cells for wound healing , 2011, Expert opinion on biological therapy.
[18] E. Sauter,et al. α1-Adrenergic Receptors Positively Regulate Toll-Like Receptor Cytokine Production from Human Monocytes and Macrophages , 2011, Journal of Pharmacology and Experimental Therapeutics.
[19] R. Isseroff,et al. Adrenergic Signaling in Human Oral Keratinocytes and Wound Repair , 2011, Journal of dental research.
[20] M. Toungouz,et al. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. , 2011, Cellular immunology.
[21] D. Federman,et al. Clinical approach to atypical wounds with a new model for understanding hypertensive ulcers. , 2010, Archives of dermatology.
[22] I. Jialal,et al. TLR2 expression and signaling-dependent inflammation impair wound healing in diabetic mice , 2010, Laboratory Investigation.
[23] G. Cai,et al. Beta-adrenergic signals regulate adipogenesis of mouse mesenchymal stem cells via cAMP/PKA pathway , 2010, Molecular and Cellular Endocrinology.
[24] R. Fischmeister,et al. A new regulation of IL-6 production in adult cardiomyocytes by beta-adrenergic and IL-1 beta receptors and induction of cellular hypertrophy by IL-6 trans-signalling. , 2010, Cellular signalling.
[25] E. Sauter,et al. Pro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent. , 2010, Molecular immunology.
[26] T. K. Hunt,et al. Human skin wounds: A major and snowballing threat to public health and the economy , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[27] Ming Xu,et al. Fenoterol, a β2-adrenoceptor agonist, inhibits LPS-induced membrane-bound CD14, TLR4/CD14 complex, and inflammatory cytokines production through β-arrestin-2 in THP-1 cell line , 2009, Acta Pharmacologica Sinica.
[28] T. Cheng,et al. DNA synthesis of rat bone marrow mesenchymal stem cells through alpha1-adrenergic receptors. , 2009, Archives of biochemistry and biophysics.
[29] R. Romieu-Mourez,et al. Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype1 , 2009, The Journal of Immunology.
[30] D. Chinkes,et al. Acute propranolol infusion stimulates protein synthesis in rabbit skin wound. , 2009, Surgery.
[31] Yukio Yoneda,et al. Functional expression of β2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells , 2009, Journal of cellular physiology.
[32] Smitha Yerrum,et al. beta2 Adrenoreceptor blockade attenuates the hyperinflammatory response induced by traumatic injury. , 2009, Surgery.
[33] David M. Rocke,et al. Stress-Mediated Increases in Systemic and Local Epinephrine Impair Skin Wound Healing: Potential New Indication for Beta Blockers , 2009, PLoS medicine.
[34] D. Jezova,et al. Low- versus High-Baseline Epinephrine Output Shapes Opposite Innate Cytokine Profiles: Presence of Lewis- and Fischer-Like Neurohormonal Immune Phenotypes in Humans? , 2008, The Journal of Immunology.
[35] J. V. Sarma,et al. Catecholamines—Crafty Weapons in the Inflammatory Arsenal of Immune/Inflammatory Cells or Opening Pandora’s Box? , 2008, Molecular medicine.
[36] Yi-Sook Jung,et al. Norepinephrine- and Epinephrine-induced Distinct β2-Adrenoceptor Signaling Is Dictated by GRK2 Phosphorylation in Cardiomyocytes* , 2008, Journal of Biological Chemistry.
[37] Ruth S. Waterman,et al. Toll‐Like Receptors on Human Mesenchymal Stem Cells Drive Their Migration and Immunomodulating Responses , 2008, Stem cells.
[38] W. Eaglstein,et al. Microscopic and physiologic evidence for biofilm‐associated wound colonization in vivo , 2008, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[39] D. Herndon,et al. Beta-blockade in burns. , 2007, Novartis Foundation symposium.
[40] R. Neubig,et al. Phagocyte-derived catecholamines enhance acute inflammatory injury , 2007, Nature.
[41] Paul G Scott,et al. Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and Angiogenesis , 2007, Stem cells.
[42] D. Greenhalgh,et al. Cutaneous Wound Healing , 2007, Journal of burn care & research : official publication of the American Burn Association.
[43] V. Falanga,et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. , 2007, Tissue engineering.
[44] S. Akira,et al. SnapShot: Pattern-Recognition Receptors , 2007, Cell.
[45] D. Herndon,et al. Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. , 2007, The Journal of trauma.
[46] Y. Helfrich,et al. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. , 2007, The Journal of clinical investigation.
[47] W. Maixner,et al. β2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-κB-independent mechanisms , 2007 .
[48] M. Kapsenberg,et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. , 2007, The Journal of investigative dermatology.
[49] Patrick M Flood,et al. Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms. , 2007, Cellular signalling.
[50] T. Billiar,et al. EMERGING PARADIGM: TOLL-LIKE RECEPTOR 4-SENTINEL FOR THE DETECTION OF TISSUE DAMAGE , 2006, Shock.
[51] F. Cunha,et al. Impaired neutrophil chemotaxis in sepsis associates with GRK expression and inhibition of actin assembly and tyrosine phosphorylation. , 2006, Blood.
[52] K. Krogfelt,et al. Multiple bacterial species reside in chronic wounds: a longitudinal study , 2006, International wound journal.
[53] R. Isseroff,et al. beta-Adrenergic receptor antagonists accelerate skin wound healing: evidence for a catecholamine synthesis network in the epidermis. , 2006, The Journal of biological chemistry.
[54] R. Isseroff,et al. β2‐Adrenergic receptor activation delays wound healing , 2006 .
[55] S. Sozzani. Dendritic cell migration , 2006 .
[56] R. Isseroff,et al. Beta2-adrenergic receptor activation delays wound healing. , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[57] J. Campisi,et al. Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines , 2005, Neuroscience.
[58] Vincent Falanga,et al. Wound healing and its impairment in the diabetic foot , 2005, The Lancet.
[59] W. Yeh,et al. IMPLICATION OF TOLL-LIKE RECEPTOR AND TUMOR NECROSIS FACTOR α SIGNALING IN SEPTIC SHOCK , 2005 .
[60] P. Lindenauer,et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. , 2005, The New England journal of medicine.
[61] R. Isseroff,et al. ß2‐adrenergic receptor activation delays dermal fibroblast‐mediated contraction of collagen gels via a cAMP‐dependent mechanism , 2005, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[62] W. Yeh,et al. Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. , 2005, Shock.
[63] R. Ulevitch,et al. Innate immune responses during infection. , 2004, Vaccine.
[64] S. Leis,et al. Catecholamine release in human skin—a microdialysis study , 2004, Experimental Neurology.
[65] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[66] R. Kirsner,et al. Microbiologic evaluation of skin wounds: alarming trend toward antibiotic resistance in an inpatient dermatology service during a 10-year period. , 2004, Journal of the American Academy of Dermatology.
[67] A. Boulton,et al. Protocol for treatment of diabetic foot ulcers. , 2004, American journal of surgery.
[68] A. Albino-Teixeira,et al. Homogeneous or heterogeneous distribution of systemically administered adrenaline: organ dependence , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.
[69] H. Wagner,et al. Differential Contribution of Toll-Like Receptors 4 and 2 to the Cytokine Response to Salmonella enterica Serovar Typhimurium and Staphylococcus aureus in Mice , 2003, Infection and Immunity.
[70] Kaori Inoue,et al. Beta2-adrenergic receptor antagonist accelerates skin barrier recovery and reduces epidermal hyperplasia induced by barrier disruption. , 2003, The Journal of investigative dermatology.
[71] R. Isseroff,et al. Beta-adrenergic receptor activation inhibits keratinocyte migration via a cyclic adenosine monophosphate-independent mechanism. , 2002, The Journal of investigative dermatology.
[72] N. Ohata,et al. Mycoplasmal Lipoproteins Induce Toll‐Like Receptor 2‐ and Caspases‐Mediated Cell Death in Lymphocytes and Monocytes , 2002, Microbiology and immunology.
[73] L. Goldman,et al. beta-Blockers and reduction of cardiac events in noncardiac surgery: scientific review. , 2002, JAMA.
[74] Robert J. Lefkowitz,et al. Seven-transmembrane-spanning receptors and heart function , 2002, Nature.
[75] T. Tani,et al. Lipopolysaccharide: neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappaB in peripheral blood mononuclear cells, even during activation. , 2001, The Journal of surgical research.
[76] G. Maestroni. Dendritic Cell Migration Controlled by α1b-Adrenergic Receptors1 , 2000, The Journal of Immunology.
[77] C. Galanos,et al. MALP-2, a Mycoplasma lipopeptide with classical endotoxic properties: end of an era of LPS monopoly? , 2000, Journal of endotoxin research.
[78] S. Akira,et al. Cutting Edge: TLR2-Deficient and MyD88-Deficient Mice Are Highly Susceptible to Staphylococcus aureus Infection1 , 2000, The Journal of Immunology.
[79] J. Pugin,et al. β-Adrenergic agonists exert their “anti-inflammatory” effects in monocytic cells through the IκB/NF-κB pathway , 2000 .
[80] G. Maestroni. Dendritic cell migration controlled by alpha 1b-adrenergic receptors. , 2000, Journal of immunology.
[81] J. Pugin,et al. beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[82] D Annane,et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. , 1999, American journal of respiratory and critical care medicine.
[83] Malcolm W Johnson. The β -Adrenoceptor , 1998 .
[84] R. Kirsner,et al. Microbiologic evaluation of cutaneous wounds in hospitalized dermatology patients. , 1998, Ostomy/wound management.
[85] G. Jung,et al. Isolation, Structure Elucidation, and Synthesis of a Macrophage Stimulatory Lipopeptide from Mycoplasma fermentans Acting at Picomolar Concentration , 1997, The Journal of experimental medicine.
[86] A. Wallace,et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. , 1996, The New England journal of medicine.
[87] G. Born,et al. Increase by adrenaline or angiotensin II of the accumulation of low density lipoprotein and fibrinogen by aortic walls in unrestrained conscious rats , 1996, British journal of pharmacology.
[88] E. Moore,et al. Evolving concepts in the pathogenesis of postinjury multiple organ failure. , 1995, The Surgical clinics of North America.
[89] J. Bergquist,et al. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[90] J. Last,et al. Nicotine- or epinephrine-induced uteroplacental vasoconstriction and fetal growth in the rat. , 1994, Toxicology.
[91] P. Howe,et al. Lack of influence of circulating adrenaline on blood pressure in normotensive and hypertensive rats. , 1994, Blood pressure.
[92] M. Bristow,et al. Protective effect of clentiazem against epinephrine-induced cardiac injury in rats. , 1993, The Journal of pharmacology and experimental therapeutics.
[93] D. Feliciano,et al. The catecholamine response to multisystem trauma. , 1992, Archives of surgery.
[94] D. Eikenburg,et al. Chronic epinephrine treatment fails to alter prejunctional adrenoceptor modulation of sympathetic neurotransmission in the rat mesentery. , 1992, The Journal of pharmacology and experimental therapeutics.
[95] Y. Yamori,et al. Adrenaline in cardiovascular diseases--effect of beta-adrenoceptor antagonists. , 1990, Zeitschrift fur Kardiologie.
[96] T. Riles,et al. Beta blockade to decrease silent myocardial ischemia during peripheral vascular surgery. , 1990, American journal of surgery.
[97] S. Trend,et al. Resistance of the rat embryo to elevated maternal epinephrine concentrations. , 1989, American journal of obstetrics and gynecology.
[98] J. Reid,et al. The Effects of Chronic Administration of Adrenaline on the Function and Number of Adrenoceptors in the Rabbit , 1988, Journal of cardiovascular pharmacology.
[99] D. Schwartz,et al. Enhanced endogenous neurotransmitter overflow in the isolated perfused rat kidney after chronic epinephrine administration: lack of a prejunctional beta adrenoceptor influence. , 1988, The Journal of pharmacology and experimental therapeutics.
[100] W. Terres,et al. Blood platelet function after chronic treatment of rats and guinea pigs with nicotine. , 1988, Klinische Wochenschrift.
[101] R. Isseroff,et al. Conversion of linoleic acid into arachidonic acid by cultured murine and human keratinocytes. , 1987, Journal of lipid research.
[102] D. Schwartz,et al. Cardiovascular responsiveness to sympathetic activation after chronic epinephrine administration. , 1986, The Journal of pharmacology and experimental therapeutics.
[103] Brian K. Kobilka,et al. Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin , 1986, Nature.
[104] W. B. Jeffries,et al. Withdrawal syndrome follows abrupt cessation of intracerebroventricular infusion of epinephrine in spontaneously hypertensive rats. , 1985, Life sciences.
[105] H. B. Stoner,et al. Plasma catecholamine concentrations in acute states of stress and trauma. , 1985, Archives of emergency medicine.
[106] P. Khairallah,et al. Adenylate Cyclase Activity in Rat Myocardium Following Chronic Infusions of Angiotensin II and Epinephrine , 1984, Journal of cardiovascular pharmacology.
[107] H. Green,et al. Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.
[108] H Green,et al. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. , 1975, Cell.